Key Facts

Invested since 2007
Based in Hesse

About the company

Zedira is a clinical stage biotech company specialized in the enzyme class of transglutaminases. Zedira performs drug discovery (e.g. celiac disease, diabetic nephropathy and thromboprophylaxis) and markets specialty reagents for R&D and diagnostics.

Do you want to

know more about this company?

Zum Artikel

Marco Winzer Partner

Marco WinzerPartner

Zedira in the news

Zum Artikel

News

20. October 2022

Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharmato Develop First-in-Class Celiac Disease Therapy

More startups from Life Sciences